Clinical Trials Directory

Trials / Completed

CompletedNCT03733743

Day-night Rhythm in Muscle Metabolism of Prediabetics

Day-night Rhythm in Muscle Metabolism of Prediabetic Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Maastricht University · Academic / Other
Sex
Male
Age
40 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study evaluates the existence of a day-night rhythm in skeletal muscle energy metabolism in prediabetic subjects. Subjects will stay at the research facility for 44 hours with a standardized living protocol during which several measurements of skeletal muscle and whole body energy metabolism will be performed.

Detailed description

Recent evidence from both observational and experimental studies indicates that disobedience of a normal day-night rhythm negatively influences metabolic and cardiovascular health, possibly leading to obesity and type 2 diabetes mellitus (T2DM). An important hallmark of obesity and T2DM is a decreased skeletal muscle mitochondrial function. Interestingly, recent research indicates that also skeletal muscle mitochondrial function is under the influence of a day-night rhythm. In this study, the presence of a day-night rhythm in skeletal muscle energy metabolism (in particular mitochondrial function) of overweight prediabetic participants will be investigated. During this study, subjects will stay at the research unit for 44 hours, with standardized meals and sleeping time. Five muscle biopsies (v. lateralis) and frequent blood draws will be taken. In addition, indirect calorimetry measurements will be performed.

Conditions

Interventions

TypeNameDescription
OTHERStandardized living protocolSubjects stay at the research facility for 44 hours and adhere to a standard sleeping, eating and activity protocol. During this protocol, multiple measurements will be performed including skeletal muscle biopsies (m. vastus lateralis), blood draws, indirect calorimetry and MRS measurements.

Timeline

Start date
2018-07-09
Primary completion
2019-03-20
Completion
2019-03-29
First posted
2018-11-07
Last updated
2019-08-16

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03733743. Inclusion in this directory is not an endorsement.